Approved Symbol |
Approved Name |
Location |
Source |
CDH15 |
cadherin 15, type 1, M-cadherin (myotubule) |
16q24.3 |
Mapped by CNV; Mapped by significant region |
NCAM1 |
neural cell adhesion molecule 1 |
11q23.2 |
Mapped by significant region |
CLDN9 |
claudin 9 |
16p13.3 |
Mapped by significant region |
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
6p21.3 |
Mapped by CNV |
NFASC |
neurofascin |
1q32.1 |
Mapped by Literature SNP |
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
11q23-q24 |
Mapped by significant region |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
6p21.3 |
Mapped by CNV |
NRXN2 |
neurexin 2 |
11q13 |
Mapped by significant region |
SIGLEC1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
20p13 |
Mapped by CNV |
SPN |
sialophorin |
16p11.2 |
Mapped by CNV |
JAM3 |
junctional adhesion molecule 3 |
11q25 |
Mapped by significant region |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
18q12.1 |
Mapped by significant region |
GLG1 |
golgi glycoprotein 1 |
16q22-q23 |
Mapped by significant region |
CADM1 |
cell adhesion molecule 1 |
11q23.2 |
Mapped by significant region |
CLDN6 |
claudin 6 |
16p13.3 |
Mapped by significant region |
NLGN1 |
neuroligin 1 |
3q26.32 |
Mapped by CNV |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
16p13.1-p11 |
Mapped by CNV |
ESAM |
endothelial cell adhesion molecule |
11q24.2 |
Mapped by significant region |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
20q13.3 |
Mapped by CNV |
HLA-DOA |
major histocompatibility complex, class II, DO alpha |
6p21.3 |
Mapped by CNV |
CNTNAP2 |
contactin associated protein-like 2 |
7q35 |
Mapped by CNV |
CD6 |
CD6 molecule |
11q12.2 |
Mapped by significant region |
CLDN5 |
claudin 5 |
22q11.21 |
Mapped by CNV |